Related Experiment Video

Updated: Jul 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Statins in stroke prevention]

Omer Gedikli1, Merih Baykan

  • 1Karadeniz Teknik Universitesi Tip Fakültesi, Kardiyoloji Anabilim Dali, Trabzon, Türkiye. omergedikli@yahoo.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|June 6, 2008
PubMed

Insights

Statins effectively reduce vascular events and stroke incidence in patients with coronary artery disease (CAD). Recent studies show high-dose atorvastatin benefits even patients with recent stroke and no known CAD.

Area of Science:

  • Cardiovascular medicine
  • Neurology
  • Pharmacology

Context:

  • Coronary artery disease (CAD) management typically involves cholesterol-lowering statins, proven to reduce vascular events.
  • Epidemiological data show limited association between cholesterol and stroke, yet clinical trials suggest otherwise.
  • Previous studies on statins and stroke have yielded mixed results, particularly regarding stroke recurrence.

Purpose:

  • To review the impact of statin therapy on stroke incidence and outcomes.
  • To explore the potential mechanisms by which statins influence stroke risk.
  • To synthesize evidence from randomized trials and subgroup analyses concerning statins and cerebrovascular events.

Summary:

  • Randomized trials demonstrate statins reduce stroke incidence by approximately 21% in patients with CAD.
  • Subgroup analyses, like the Heart Protection Study, showed simvastatin did not impact stroke recurrence in prior stroke patients.
  • The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial indicated high-dose atorvastatin significantly reduced stroke risk in patients with recent stroke/TIA, even without known CAD.

Impact:

  • Statin therapy is crucial for secondary prevention of stroke in CAD patients.
  • High-dose statins may offer cerebrovascular protection beyond CAD management, as suggested by the SPARCL trial.
  • Further research into the mechanisms of statin action on stroke is warranted to optimize therapeutic strategies.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...